Filing Details
- Accession Number:
- 0001179110-10-011629
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-07-14 13:00:00
- Reporting Period:
- 2010-07-12
- Filing Date:
- 2010-07-14
- Accepted Time:
- 2010-07-14 16:49:01
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1142596 | Nuvasive Inc | NUVA | Surgical & Medical Instruments & Apparatus (3841) | 330768598 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1330401 | Jason Hannon | 7475 Lusk Blvd. San Diego CA 92121 | Evp And General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2010-07-12 | 1,574 | $16.24 | 3,129 | No | 4 | M | Direct | |
Common Stock | Disposition | 2010-07-12 | 1,574 | $35.00 | 1,555 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2010-07-12 | 426 | $18.31 | 1,981 | No | 4 | M | Direct | |
Common Stock | Disposition | 2010-07-12 | 426 | $35.00 | 1,555 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2010-07-12 | 1,574 | $0.00 | 1,574 | $16.24 |
Common Stock | Stock Option (Right to Buy) | Disposition | 2010-07-12 | 426 | $0.00 | 426 | $18.31 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2009-06-21 | 2015-06-21 | No | 4 | M | Direct |
20,402 | 2010-01-03 | 2016-01-03 | No | 4 | M | Direct |
Footnotes
- The shares sold were acquired contemporaneously upon the cashless exercise of a stock option at an exercise price of $16.24 per share.
- The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 9, 2009, which is intended to comply with Rule 10b5-1.
- The shares sold were acquired contemporaneously upon the cashless exercise of a stock option at an exercise price of $18.31 per share.